CSIR Technology Portal
CSIR Technology Portal

 Technology Profile

Title:

Herbal Composition for Treating Asthma

Value Proposition:

The invention provides a method for the treatment of asthma, employing principles extracted from the plant Murraya koenigii. The leaf of this plant is widely used in various food preparations in India. Further, the plant is ubiquitous. Thus the prior art suggests that the extracts of the plant have several medicinal and other properties which have been widely investigated. This is adequate proof that the extracts of the plant can be safely consumed by humans without any side effects.
The invention also provides a simple, fast and inexpensive process for preparing an extract from the plant and obtains a mixture of active (four) compounds possessing biological activities useful in the treatment of asthma. The process comprising the steps of pulverising plant parts, extracting the plant pulverized parts with a solvent at ambient temperature, concentrating the extract by filtering and evaporating it under reduced pressure and lyophilizing the concentrate to obtain a lyophilized extract containing active principles of the plant Murraya koenigii.
The innovation also constitutes novel compositions useful in the treatment of asthma and methods for the extraction of active principles from the plant Murraya koenigii.

Summary Application:

The herbal composition finds usefulness for relief, treatment and cure of asthmatic problem.

Advantages:

It is expected to provide relief, treatment and cure of asthmatic problem satisfactorily.
It is prepared from a plant material, which has been used in food for centuries and is biocompatible and non-toxic.
The plant is abundantly available.
Method of preparation of the active material /principle is simple, fast and inexpensive. he method of administration of the plant material is also simple.
Its cultivation and propagation is easy as it grows an all kinds of soil.
There has been no case of relapse during the observation time of 6 months. No adverse or side effects were observed after the treatment.

Commercialization Status: Already Commercialised
Tech. Readiness Level:
CSIR-Indian Institute of Chemical Biology
CSIR-Indian Institute of Chemical Biology[CSIR-IICB]
:  director[at]iicb[dot]res[dot]in
:91-33-24730492
:https://iicb.res.in/
Industrial Applications: Formulations [Drugs and Pharmaceuticals]
Photograph(s)